173 related articles for article (PubMed ID: 12496688)
21. Cervical neoplasia: are adjunctive tests to cervical cytology worthwhile?
Greenberg MD; Sedlacek TV; Campion MJ
Clin Obstet Gynecol; 1995 Sep; 38(3):600-9. PubMed ID: 8612370
[No Abstract] [Full Text] [Related]
22. Human papillomavirus DNA testing in community screening for diseases of the cervix uteri.
Chan SY
Clin Sci (Lond); 1996 Sep; 91(3):250-2. PubMed ID: 8869401
[No Abstract] [Full Text] [Related]
23. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
24. Role of HPV-assay as an adjuvant to Pap's smear for diagnosis of carcinoma cervix.
Shahi SK; Ranga S; Srivastava R
Indian J Pathol Microbiol; 2000 Oct; 43(4):383-5. PubMed ID: 11344599
[No Abstract] [Full Text] [Related]
25. Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports.
Kühler-Obbarius C; Milde-Langosch K; Helling-Giese G; Salfelder A; Peimann C; Löning T
Virchows Arch; 1994; 425(2):157-63. PubMed ID: 7952500
[TBL] [Abstract][Full Text] [Related]
26. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus PCR direct sequencing study of cervical precancerous lesions in Quebec children.
Oligny LL; Feoli-Fonseca JC; Brochu P; Simard P; Falconi S; Yotov WV
Sex Transm Infect; 2001 Oct; 77(5):391. PubMed ID: 11588297
[No Abstract] [Full Text] [Related]
28. Quantitative tests for human papillomavirus.
Johnston C
Lancet; 2000 Jun; 355(9222):2179-80. PubMed ID: 10881885
[No Abstract] [Full Text] [Related]
29. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
30. [Papillomavirus screening: shall it be performed systematically?].
Agius G; Beby-Defaux A
Transfus Clin Biol; 2003 Apr; 10(2):86-9. PubMed ID: 12763151
[No Abstract] [Full Text] [Related]
31. [Testing for human papillomavirus in cervical cancer screening].
Kjaer SK
Ugeskr Laeger; 2002 Jan; 164(2):173-5. PubMed ID: 11831083
[No Abstract] [Full Text] [Related]
32. Natural history of cervical human papillomavirus.
Diakomanolis E; Stefanidis K; Rodolakis A
Lancet; 2001 Nov; 358(9292):1551-2. PubMed ID: 11705602
[No Abstract] [Full Text] [Related]
33. Human papillomavirus (HPV) in high-grade cervical intraepithelial neoplasia (CIN) detected by morphology and polymerase chain reaction (PCR)-- a cytohistologic correlation of 277 cases treated by laser conization.
Lie AK; Isaksen CV; Skarsvåg S; Haugen OA
Cytopathology; 1999 Apr; 10(2):112-21. PubMed ID: 10211617
[TBL] [Abstract][Full Text] [Related]
34. Correspondence re: Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, et al. "Ascus, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol 1999;12:335-42.
Koss LG
Mod Pathol; 2000 Feb; 13(2):208-9. PubMed ID: 10697279
[No Abstract] [Full Text] [Related]
35. Testing for human papillomavirus: data driven implications for cervical neoplasia management.
Stoler MH
Clin Lab Med; 2003 Sep; 23(3):569-83, v. PubMed ID: 14560529
[TBL] [Abstract][Full Text] [Related]
36. Detection of human papillomaviruses (HPV-16,18) in cervical smears by in situ hybridization.
Marin J; Ursic-Vrscaj M; Erzen M
Isr J Med Sci; 1994; 30(5-6):448-50. PubMed ID: 8034501
[TBL] [Abstract][Full Text] [Related]
37. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
[TBL] [Abstract][Full Text] [Related]
40. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
